Sensorion gets EMA’s Agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications
Sensorion gets EMA’s agreemtn, which paves the way for the submission of a marketing authorization application in Europe
Pharmaceuticals, Biotechnology and Life Sciences
Sensorion gets EMA’s agreemtn, which paves the way for the submission of a marketing authorization application in Europe
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
– At 48 weeks, 98% of patients treated with SOLIRIS were relapse free compared to 63% of patients receiving placebo…
International Science and Technology Innovation Center Forum Nobel and Turing Award Winners Hong Kong Summit HONG KONG–(BUSINESS WIRE)–The first day…
BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric…
HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase…
HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
Global medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan market Nationally proven high-touch, provider-based…